 |
The 130th Annual Meeting of APHA |
|
The 130th Annual Meeting of APHA |
Daniel Gentry, PhD, MHA, Associate Professor of Health Management and Policy, Saint Louis University School of Public Health, Center for HIV/STD Policy Studies, Salus Center Suite 300, 3545 Lafayette Avenue, St. Louis, MO 63104, (314) 977-8152, dgentry@slu.edu, ThuVan T. Dinh, MPH, Center for HIV/STD Policy Studies, Saint Louis University School of Public Health, 3545 Lafayette Avenue, Salus Center, Suite 300, St. Louis, MO 63104-1314, Emily Gantz McKay, MA, Mosaica, 1522 K Street, NW, Suite 1130, Washington, DC 20005, Aisha Gilliam, EdD, Program Evaluation Research Branch, Centers for Disease Control and Prevention, Division of HIV/AIDS Prevention, 1600 Clifton Road NE, Mail Stop E-59, Atlanta, GA 30333, Samuel Taveras, MEd, Division of HIV/AIDS Prevention/Capacity Building Branch, Centers for Disease Control and Prevention/NCHSTP, 1600 Clifton Road NE, Mail Stop E-40, Atlanta, GA 30333, and Donata Green, PhD, Capacity Building Branch, Division of HIV/AIDS Prevention, CDC Center for HIV/STD/TB Prevention, 8 Corporate Blvd., Atlanta, GA 30333.
Background: National initiatives for HIV prevention involve and affect many stakeholders. The CDC uses a broad-based approach for building HIV prevention capacity among racial and ethnic minority communities. These efforts involve CDC programs and staff, community-based organizations (CBOs), CDC directly funded health departments, and capacity building service providers (CBAs). Purpose: In the context of a national project to evaluate one of CDC's initiatives to build HIV prevention capacity in minority communities, multiple strategies were used to involve all stakeholders in (1) providing input and feedback about evaluation plans and (2) serving as sources of important information during the evaluation. This presentation will provide a rationale for stakeholder inclusion, further description of stakeholder involvement, specific methods to elicit stakeholder participation, and results of stakeholder input. Methods: Stakeholder involvement was achieved through several methods, including constitution of an evaluation stakeholders panel (ESP) at the beginning of the 3-year project, a series of face-to-face focus groups, and a series of telephone interviews. Data analysis, focusing narrowly on a priori research questions and broadly on naturally occurring themes, was accomplished through qualitative data analysis. Results: Meetings and conference calls were held for the ESP to solicit input and feedback; focus groups were held with CDC staff working with CBAs and CBOs; individual interviews were conducted for a representative sample of minority CBOs; a focus group was conducted with a sample of health departments; focus groups were conducted with CBAs. Results from individual stakeholder groups and aggregate data will be shared.
Learning Objectives: By the end of this presentation, audience members will
Keywords: HIV/AIDS, Evaluation
Presenting author's disclosure statement:
I do not have any significant financial interest/arrangement or affiliation with any organization/institution whose products or services are being discussed in this session.